Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-19 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-18 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-12 |
mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-06 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-09 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-17 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-13 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-14 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
mRNA | FEV | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |